3.22.2 html 153 213 1 false 44 0 false 4 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100030 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 100050 - Statement - Condensed Consolidated Statements of Convertible Preferred Units and Stockholders' Equity/ Members' (Deficit) (Unaudited) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfConvertiblePreferredUnitsAndStockholdersEquityMembersDeficitUnaudited Condensed Consolidated Statements of Convertible Preferred Units and Stockholders' Equity/ Members' (Deficit) (Unaudited) Statements 5 false false R6.htm 100060 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100070 - Disclosure - Organization and Description of Business Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 7 false false R8.htm 100080 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100090 - Disclosure - Fair Value Measurements Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 9 false false R10.htm 100100 - Disclosure - Investments Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureInvestments Investments Notes 10 false false R11.htm 100110 - Disclosure - Collaboration Revenue Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureCollaborationRevenue Collaboration Revenue Notes 11 false false R12.htm 100120 - Disclosure - Leases Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureLeases Leases Notes 12 false false R13.htm 100130 - Disclosure - Debt Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/DisclosureDebt1 Debt Notes 13 false false R14.htm 100140 - Disclosure - Warrants Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/DisclosureWarrants Warrants Notes 14 false false R15.htm 100150 - Disclosure - Stock-Based Compensation Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensation Stock-Based Compensation Notes 15 false false R16.htm 100160 - Disclosure - Net Loss Per Share Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureNetLossPerShare Net Loss Per Share Notes 16 false false R17.htm 100170 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 17 false false R18.htm 100180 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurements 18 false false R19.htm 100190 - Disclosure - Investments (Tables) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureInvestmentsTables Investments (Tables) Tables http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureInvestments 19 false false R20.htm 100200 - Disclosure - Leases (Tables) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureLeasesTables Leases (Tables) Tables http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureLeases 20 false false R21.htm 100210 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensation 21 false false R22.htm 100220 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureNetLossPerShare 22 false false R23.htm 100230 - Disclosure - Organization and Description of Business - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails Organization and Description of Business - Additional Information (Details) Details 23 false false R24.htm 100240 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 24 false false R25.htm 100250 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy (Details) Details 25 false false R26.htm 100260 - Disclosure - Fair Value Measurements - Changes In Fair Values of Convertible Preferred Stock Warrants and Common Stock Warrants, Classified as Level 3 Financial Liabilities (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementsChangesInFairValuesOfConvertiblePreferredStockWarrantsAndCommonStockWarrantsClassifiedAsLevel3FinancialLiabilitiesDetails Fair Value Measurements - Changes In Fair Values of Convertible Preferred Stock Warrants and Common Stock Warrants, Classified as Level 3 Financial Liabilities (Details) Details 26 false false R27.htm 100270 - Disclosure - Investments - Schedule of Fair Value Amortized Cost and Unrealized Gain and Loss of Investments in Marketable Securities (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureInvestmentsScheduleOfFairValueAmortizedCostAndUnrealizedGainAndLossOfInvestmentsInMarketableSecuritiesDetails Investments - Schedule of Fair Value Amortized Cost and Unrealized Gain and Loss of Investments in Marketable Securities (Details) Details 27 false false R28.htm 100280 - Disclosure - Investments - Schedule of Fair Value of Marketable Debt Securities by Maturity Date (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureInvestmentsScheduleOfFairValueOfMarketableDebtSecuritiesByMaturityDateDetails Investments - Schedule of Fair Value of Marketable Debt Securities by Maturity Date (Details) Details 28 false false R29.htm 100290 - Disclosure - Collaboration Revenue - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureCollaborationRevenueAdditionalInformationDetails Collaboration Revenue - Additional Information (Details) Details 29 false false R30.htm 100300 - Disclosure - Leases - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 30 false false R31.htm 100310 - Disclosure - Leases - Schedule of Future Minimum Payments Under Operating Lease Liabilities (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureLeasesScheduleOfFutureMinimumPaymentsUnderOperatingLeaseLiabilitiesDetails Leases - Schedule of Future Minimum Payments Under Operating Lease Liabilities (Details) Details 31 false false R32.htm 100320 - Disclosure - Debt - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/DisclosureDebtAdditionalInformationDetails Debt - Additional Information (Details) Details 32 false false R33.htm 100330 - Disclosure - Warrants Additional Information (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails Warrants Additional Information (Details) Details 33 false false R34.htm 100340 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 34 false false R35.htm 100350 - Disclosure - Stock-Based Compensation - Summary of Recognized Stock-Based Compensation (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRecognizedStockBasedCompensationDetails Stock-Based Compensation - Summary of Recognized Stock-Based Compensation (Details) Details 35 false false R36.htm 100360 - Disclosure - Net Loss Per Share - Summary of Outstanding Shares Have Been Excluded from Computation of Diluted Net Loss Per Share Because Their Effect Would have Been Anti-Dilutive (Details) Sheet http://www.dicetherapeutics.com/20220630/taxonomy/role/Role_DisclosureNetLossPerShareSummaryOfOutstandingSharesHaveBeenExcludedFromComputationOfDilutedNetLossPerShareBecauseTheirEffectWouldHaveBeenAntiDilutiveDetails Net Loss Per Share - Summary of Outstanding Shares Have Been Excluded from Computation of Diluted Net Loss Per Share Because Their Effect Would have Been Anti-Dilutive (Details) Details 36 false false All Reports Book All Reports dice-20220630.htm dice-20220630.xsd dice-20220630_cal.xml dice-20220630_def.xml dice-20220630_lab.xml dice-20220630_pre.xml dice-ex10_1.htm dice-ex31_1.htm dice-ex31_2.htm dice-ex32_1.htm dice-ex32_2.htm dice-ex4_1.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true